Login to Your Account



Early Success Reported in hESC Trial for Macular Degeneration

By Nuala Moran
BioWorld International Correspondent

Wednesday, January 25, 2012
LONDON – The first patient in the first human embryonic stem cell (hESC) trial to be held in Europe left Moorfields Eye Hospital in London Monday after being treated for macular degeneration.

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription